Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis

Oncogene

Volumn 18, Issue 24, 1999, Pages 3574-3582

  Stickeler, Elmar ^a   Kittrell, Frances ^a   Medina, Daniel ^a   Berget, Susan M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative splicing; CD44; Mammary tumorigenesis; Mouse model; SR splicing factors

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER MODEL; EXON; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; EPITHELIAL CELLS; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; LUNG NEOPLASMS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PRECANCEROUS CONDITIONS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033578006     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202671     Document Type: Article

References (54)

1. Bell MV, Cowper AE, Lefranc MP, Bell JI and Screaton GR. (1998). Mol. Cell. Biol., 18, 5930-5941.
2. Berget SM. (1995). J. Biol. Chem., 270, 2411-2414.
3. Black DL. (1995). RNA, 1, 763-771.
4. Cáceres JF, Stamm S, Helfman DM and Krainer AR. (1994). Science, 265, 1706-1709.
5. Cáceres JF and Krainer AR. (1997). In: Mammalian pre-mRNA splicing factors. Krainer AR (ed.). IRL Press: Oxford. pp. 174-212.
6. Cannistra S, Abu-Jawdeh G and Niloff J. (1995). J. Clin. Oncol., 13, 1912-1921.
7. Cardiff RD. (1988). Anticancer Res., 8, 925-933.
8. Chandler SD, Mayeda A, Yeakley JM, Krainer AR and Fu X-D. (1997). Proc. Natl. Acad. Sci. USA, 94, 3596-3601.
9. East JA and Hart IR. (1993). Eur. J. Cancer, 29A, 1921-1922.
10. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A and Simmons D. (1994). Cancer Res., 54, 4539-4546.
11. Friedrichs K, Kugler G, Franke F, Terpe HJ, Arlt J, Regidor PA and Gunthert U. (1995). Lancet, 345, 1237.
12. Fu X-D. (1993). Nature, 365, 82-85.
13. Fu X-D. (1995). RNA, 1, 663-680.
14. Ge H and Manley JL. (1990). Cell, 62, 25-34.
15. Ge H, Zuo P and Manley JL. (1991). Cell, 66, 373-382.
16. Gunthert U, Hoffmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H and Herrlich P. (1991). Cell, 65, 13-24.
17. Gunthert U. (1993). Curr. Microbiol. and Immunol., 184, 47-63.
18. Haynes BF, Hua-Xin L and Patton KL. (1990). Cancer Cells, 3, 347-350.
19. Heider KH, Mulder JW, Ostermann E, Susanni S, Patzelt E, Pals ST and Adolf GR. (1995). Eur. J. Cancer, 31A, 2385-2391.
20. Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D and Butel JS. (1993). Cancer Res., 53, 3374-3381.
21. Joensuu H, Klemi P, Toikkanen S and Jalkanen S. (1993). Am. J. Path., 143, 867-874.
22. Kittrell FS, Oborn CJ and Medina D. (1992). Cancer Res., 52, 1924-1932.
23. Krainer AR, Conway GC and Kozak D. (1990a). Genes Dev., 4, 1158-1171.
24. Krainer AR, Conway GC and Kozak D. (1990b). Cell, 62, 35-42.
25. Kramer A. (1996). Annu. Rev. Biochem., 65, 367-409.
26. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H and Herrlich P. (1995). Lancet, 345, 615-619.
27. König H, Ponta H and Herrlich P. (1998). EMBO J., 17, 2904-2913.
28. Lee MP and Feinberg AP. (1997). Cancer Res., 57, 3131-3134.
29. Liu H-X, Zhang M and Krainer AR. (1998). Genes Dev., 12, 1990-2012.
30. Mackay C, Terpe HJ, Stauder R, Marston WL, Stark H and Gunthert U. (1994). J. Cell. Biol., 124, 71-82.
31. Manley J and Tacke R. (1996). Genes Dev., 10, 1569-1579.
32. Medina D. (1996). In: Mammary Tumor Cell Cycle, Differentiation and Metastases. Dickson RB and Lippman ME. (eds). Academic Publishers: Norwell, pp. 37-69.
33. Moore MJ, Query CC and Sharp PA. (1993). In: The RNA World. Gesteland RF and Atkins JF. (eds). Cold Spring Harbor Laboratory Press: New York. pp. 303-357.
34. Muller W, Schneiders A, Heider KH, Meier S, Hommel G and Gabbert HE. (1997). J. Pathol., 183, 222-227.
35. Neugebauer KM and Roth M. (1997). Genes Dev., 11, 1148-1159.
36. Norton PA. (1994). J. Cell. Sci., 107, 1-7.
37. Reed R. (1996). Curr. Opin. Genet. Dev., 6, 215-220.
38. Rio DC. (1993). Curr. Opin. Genet. Dev., 3, 574-584.
39. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U and Bell JI. (1992). Proc. Natl. Acad. Sci. USA, 89, 12160-12164.
40. Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI and Krainer AR. (1995). EMBO J., 14, 4336-4349.
41. Silberstein GB, Van Horn K, Strickland P, Roberts Jr CT and Daniel CW. (1997). Proc. Natl. Acad. Sci. USA, 94, 8132-8137.
42. Sinn HP, Heider KH, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P and Ponta P. (1995). Breast Cancer Res. Treat. 36, 307-313.
43. Stamenkovic I, Amiot M, Pesando JM and Seed B. (1989). Cell, 56, 1057-1062.
44. Stickeler E, Runnebaum IB, Moebus VJ, Kieback DG and Kreienberg R. (1997). Anticancer Res., 17, 1871-1876.
45. Sun Q, Mayeda A, Hampson RK, Krainer AR and Rottman FM. (1993). Genes Dev., 7, 2598-2608.
46. Tran TA, Kallakury BV, Sheehan CE and Ross JS. (1997). Hum. Pathol., 28, 809-814.
47. Valcarcel J and Green MR. (1996). Trends Biochem. Sci., 21, 296-301.
48. Wang J and Manley JL. (1995). RNA, 1, 335-346.
49. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlick P and Pals ST. (1993). Cancer Res., 53, 4754-4756.
50. Zamore PD, Patton JG and Green MR. (1992). Nature, 355, 609-614.
51. Zahler AM, Lane WS, Stolk JA and Roth MB. (1992). Genes Dev., 6, 837-847.
52. Zahler AM, Neugebauer KM, Lane WS and Roth MB. (1993a). Science, 260, 219-222.
53. Zahler AM, Neugebauer KM, Stolk JA and Roth MB. (1993b). Mol. Cell. Biol., 13, 4023-4028.
54. Zhu X, Daffada AA, Chan CM and Dowsett M. (1997). Int. J. Cancer, 72, 574-580.